Latest News and Press Releases
Want to stay updated on the latest news?
-
RESEARCH TRIANGLE PARK, N.C., Feb. 5, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 10th Annual BIO CEO and Investor Conference...
-
FDA Accepts Icagen's IND for Senicapoc as a Potential Treatment for Asthma Dosing to Begin in Phase Ib Clinical Trial During January RESEARCH TRIANGLE PARK,...
-
RESEARCH TRIANGLE PARK, N.C., Jan. 3, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 26th Annual JPMorgan Healthcare Conference...
-
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2007 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that P. Kay Wagoner, Ph.D., President and Chief Executive Officer, and Richard D. Katz, M.D.,...
-
RESEARCH TRIANGLE PARK, N.C., Oct. 29, 2007 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that Dr. Neil Castle, Director of Biology at Icagen, and Dr. Aaron Gerlach, Ph.D., Senior...
-
RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2007 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release third quarter 2007 financial results on Friday, November 2, 2007. The...